Christophe Soulier
Directeur Financier/CFO chez Janssen Pharmaceuticals, Inc.
Postes actifs de Christophe Soulier
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Directeur Financier/CFO | 01/11/2007 | - |
Johnson & Johnson Innovation Ltd.
 Johnson & Johnson Innovation Ltd. Investment ManagersFinance Johnson & Johnson Innovation Ltd is a private equity subsidiary of Johnson & Johnson Innovation - JJDC, Inc. founded in 2000. The firm is headquartered in Buckinghamshire, United Kingdom. | Private Equity Investor | 08/02/2023 | - |
Historique de carrière de Christophe Soulier
Anciens postes connus de Christophe Soulier
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| JOHNSON & JOHNSON | Directeur Financier/CFO | 01/04/2005 | 01/10/2007 |
| Private Equity Investor | 01/08/2002 | 01/04/2005 |
Formation de Christophe Soulier
| University of Michigan | Masters Business Admin |
| Collège Stanislas de Paris | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Royaume-Uni | 2 |
| France | 2 |
Opérationnelle
| Director of Finance/CFO | 2 |
| Private Equity Investor | 2 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Entreprise privées | 2 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Johnson & Johnson Innovation Ltd.
Johnson & Johnson Innovation Ltd. Investment ManagersFinance Johnson & Johnson Innovation Ltd is a private equity subsidiary of Johnson & Johnson Innovation - JJDC, Inc. founded in 2000. The firm is headquartered in Buckinghamshire, United Kingdom. | Finance |
- Bourse
- Insiders
- Christophe Soulier
- Expérience